New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
We’re defending and empowering allergists
The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.
AllergyTalk is now a vodcast
You’ve heard their voices and trusted their expertise. Now it’s time to see the conversation unfold in the first video podcast episode.
The new era of health AI: what allergists need to know
For the first time, large scale AI platforms are being built explicitly for health care delivery rather than adapted from consumer tools.
ACAAI applauds the latest expansion of GME slots
CMS announced the distribution of 400 new federally funded graduate medical education residency positions to hospitals across the country.
Read about atopic dermatitis and itch this month
It is a timely topic as most of the USA is dealing with very cold weather and dry conditions, and itching is a challenging clinical problem.
Medicare payment policies expire again
A brief lapse in funding is unlikely to trigger a full government shutdown of the agencies funded by the minibus
Claim denials for CPT code 95165 are growing
These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.
Member benefit: employment contract service
The College has partnered with Resolve, a national firm specializing in physician employment contracts, to offer a valuable member benefit. Resolve provides ph…
January-February AllergyWatch targets nanobody molecules for asthma and more
In the current issue, you’ll find information about the use of nanobody molecules for asthma treatment, plus additional articles.
… results in College Insider.
